Bio-Techne Corp at Citi Healthcare Conference (Virtual) Transcript
Well, great. Thank you all for joining us at the Citi Conference here. I'm Patrick Donnelly, the Tools and Diagnostics Analyst at Citi.
Happy to have Jim Hippel, CFO of Techne; and Dave Clair from the IR team. And we can dive right in, Jim.
Questions & Answers
I guess, going back a few weeks, you guys reported a pretty clean beat in your fiscal 2Q. Protein Sciences continues to be a source of strength. Maybe just at a high level, we can start with the quarter, maybe talk through kind of the moving pieces and then we can kind of dive into some more specific questions.
Yes. I mean it was a great quarter. It was a very strong broad-based growth quarter as it has been now for many quarters in a row for our business. As you mentioned, the Protein Science, in particular, is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
